Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial (SIT)

Clinical Trial ID NCT00072761

PubWeight™ 33.24‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00072761

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia. N Engl J Med 2014 3.25
2 Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction. J Pediatr 2014 2.00
3 Design of the silent cerebral infarct transfusion (SIT) trial. Pediatr Hematol Oncol 2010 1.87
4 Silent Cerebral Infarct Transfusion (SIT) trial imaging core: application of novel imaging information technology for rapid and central review of MRI of the brain. J Digit Imaging 2008 1.52
5 Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal 2012 1.40
6 Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure. Blood 2011 1.37
7 Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood 2012 1.37
8 Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 2012 1.26
9 Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet 2011 1.24
10 Parent education and biologic factors influence on cognition in sickle cell anemia. Am J Hematol 2014 1.22
11 Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012 1.12
12 Acute silent cerebral ischemic events in children with sickle cell anemia. JAMA Neurol 2013 1.10
13 Sickle cell disease. Hematology Am Soc Hematol Educ Program 2004 1.09
14 Elevation of IgE in children with sickle cell disease is associated with doctor diagnosis of asthma and increased morbidity. J Allergy Clin Immunol 2011 1.06
15 A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. PLoS One 2012 1.04
16 Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Am J Hematol 2011 1.03
17 Incidental findings on brain magnetic resonance imaging of children with sickle cell disease. Pediatrics 2010 0.92
18 Prospects for primary stroke prevention in children with sickle cell anaemia. Br J Haematol 2012 0.89
19 Sickle cell disease in childhood: from newborn screening through transition to adult medical care. Pediatr Clin North Am 2013 0.89
20 RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood 2010 0.87
21 Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease. Acad Emerg Med 2012 0.86
22 Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia. Br J Haematol 2013 0.85
23 Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. Br J Haematol 2012 0.84
24 Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. Am J Hematol 2014 0.80
25 A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care. Adv Ther 2015 0.80
26 Health-related quality of life in children with sickle cell anemia: impact of blood transfusion therapy. Am J Hematol 2015 0.79
27 Sickle cell disease in children. Drugs 2012 0.78
28 Hemoglobin depletion from plasma: considerations for proteomic discovery in sickle cell disease and other hemolytic processes. Proteomics Clin Appl 2010 0.77
29 Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease. Proteomics Clin Appl 2014 0.75
Next 100